Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity

By Lazar Andreas   Gründemann Dirk   Schömig Edgar  

Molecular Diagnosis & Therapy, Vol. 11, Iss. 5, 2007-01 ,pp. : 341-341

Adis International

Access to resources Recommend Favorite

Genetic and mechanistic evaluation for the weak A phenotype in Ael blood type with IVS6 + 5G>A ABO gene mutation

By  

VOX SANGUINIS, Vol. 108, Iss. 1, 2015-01 ,pp. : 64-71

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low and fixed dose of hydroxyurea is effective and safe in patients with HbSβ+ thalassemia with IVS1‐5(G→C) mutation

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 6, 2015-06 ,pp. : 1017-1023

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to “A Case of 5‐FU‐Related Severe Toxicity Associated With the P.Y186C DPYD Variant”

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 137-137

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case of 5‐FU‐Related Severe Toxicity Associated with the p.Y186C DPYD Variant

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 95, Iss. 2, 2014-02 ,pp. : 136-136

John Wiley & Sons Inc

Access to resources Recommend Favorite